News for Immunocore Holdings Stock (IMCR)

Immunocore Holdings plc (IMCR) Q4 2023 Earnings Call Transcript

Seeking Alpha • 02/28/24

Immunocore reports fourth quarter and full year 2023 financial results and provides a business update

GlobeNewsWire • 02/28/24

Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial

GlobeNewsWire • 02/22/24

Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024

GlobeNewsWire • 02/21/24

5 Biotech Stocks to Consider for Your Portfolio in 2024

Zacks Investment Research • 02/13/24

Immunocore Holdings PLC Sponsored ADR (IMCR) Moves 6.9% Higher: Will This Strength Last?

Zacks Investment Research • 02/01/24

Immunocore Prices Upsized Convertible Senior Notes Offering

GlobeNewsWire • 01/31/24

Immunocore Announces Proposed Convertible Senior Notes Offering

GlobeNewsWire • 01/29/24

Should You Buy Immunocore Holdings PLC Sponsored ADR (IMCR) After Golden Cross?

Zacks Investment Research • 01/10/24

Best Momentum Stocks to Buy for January 10th

Zacks Investment Research • 01/10/24

New Strong Buy Stocks for January 10th

Zacks Investment Research • 01/10/24

Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation

GlobeNewsWire • 01/05/24

Immunocore to present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewsWire • 01/03/24

Immunocore Holdings PLC Sponsored ADR (IMCR) Upgraded to Buy: Here's What You Should Know

Zacks Investment Research • 12/18/23

How Much Upside is Left in Immunocore Holdings PLC Sponsored ADR (IMCR)? Wall Street Analysts Think 30.32%

Zacks Investment Research • 12/13/23

Can Immunocore Holdings PLC Sponsored ADR (IMCR) Climb 75.55% to Reach the Level Wall Street Analysts Expect?

Zacks Investment Research • 11/27/23

Bears are Losing Control Over Immunocore Holdings PLC Sponsored ADR (IMCR), Here's Why It's a 'Buy' Now

Zacks Investment Research • 11/20/23

Wall Street Analysts See a 66.42% Upside in Immunocore Holdings PLC Sponsored ADR (IMCR): Can the Stock Really Move This High?

Zacks Investment Research • 11/10/23

Immunocore Reports Third Quarter 2023 Financial Results and Provides Business Update

GlobeNewsWire • 11/07/23

Immunocore: First Half Of 2024 IMC-F106C Data Expected

Seeking Alpha • 11/01/23

Immunocore announces upcoming poster presentations at SITC Annual Meeting 2023 and SMR Congress 2023

GlobeNewsWire • 11/01/23

Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial

GlobeNewsWire • 10/21/23

Wall Street Analysts See a 60.86% Upside in Immunocore Holdings PLC Sponsored ADR (IMCR): Can the Stock Really Move This High?

Zacks Investment Research • 10/19/23

Immunocore announces upcoming presentation and posters at ESMO 2023

GlobeNewsWire • 10/06/23

Institutions are Buying These 3 Stocks and Analysts Agree

MarketBeat • 09/07/23